Discussions by the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry structure are reaching the last lap. Its final report - a draft of which will be presented later this month - is expected to…
HOME > BUSINESS
BUSINESS
- Medical System Network President Calls for Scrapping Fee Cut Rule
January 21, 2015
- Sakura Finetek Japan to Participate in Cervical Cancer Screening Project in Kazakhstan
January 21, 2015
- Meiji Seika Pharma Licenses Darinaparsin from Solasia Pharma in Japan
January 20, 2015
- Sanofi Launches Allegra Dry Syrup for Pediatric Patients Aged 6 Months and Older
January 20, 2015
- Pharma Bigwigs Stress Importance of Early Patent Strategies
January 19, 2015
- Foreign-Affiliated Pharmas Looking to Make “Sure Investments” to Avoid Risk of Discontinued Development: PhRMA Official
January 19, 2015
- Mr Plata Named as AbbVie G.K.’s New President
January 19, 2015
- Belsomra Most Heavily Pitched Drug in November: Anterio Ranking
January 16, 2015
- Toyama Chemical Commences PII Study for Solithromycin in Japan
January 16, 2015
- Sumitomo Dainippon Files Latuda Patent Infringement Lawsuits in US against 3 Pharmas
January 16, 2015
- Otsuka Completes Acquisition of Avanir for US$3.56 Billion
January 15, 2015
- Lantus Biosimilar Approved: Eli Lilly Japan, NBI
January 15, 2015
- Takeda to Roll Out Colcrys AG in US
January 14, 2015
- Meiji, Roche, Fedora Tie Up for Development, Commercialization of Beta-Lactamase Inhibitor
January 14, 2015
- Ethical Drug Sales Down 7.6% in November: Crecon Report
January 14, 2015
- Daiichi Sankyo Reaches Settlement with US DOJ Following Investigation of Promotional Activities; to Pay US$39 Million
January 14, 2015
- GSK, Nippon Kayaku to End Copromotion of Cancer Drug Tykerb
January 13, 2015
- Otsuka, Fuso to Terminate Cancer Vaccine Deals with OncoTherapy
January 13, 2015
- FDA Approves Edoxaban for AF, VTE: Daiichi Sankyo
January 13, 2015
- GSK Japan Unit to Cut Jobs amid Global Restructuring Move
January 9, 2015
ページ
Whenever an excellent employee or leader leaves, it’s a blow to your organization.The departure of staff is an inevitable part of business, but in a fiercely competitive recruitment landscape like Japan, employee retention is a priority.Not only does retaining staff…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…